Insider Transactions in Q4 2020 at Nurix Therapeutics, Inc. (NRIX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2020
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$0
$0.84 P/Share
|